stockrowGlass House Brands Inc. (GLAS) vs Lifecore Biomedical, Inc. (LFCR)
- Glass House Brands Inc. GLAS 2.28 −11.63%
- Lifecore Biomedical, Inc. LFCR 6.39 −0.78%
Glass House Brands Inc. and Lifecore Biomedical, Inc. are both Drug Manufacturers Specialty & Generic companies. Lifecore Biomedical, Inc. is the larger, with a market value of $242.6M against $172.7M — 1.4× the size. Glass House Brands Inc. grew revenue faster over the last twelve months: −15.4% against −18.2%. Glass House Brands Inc. has the higher net margin (−36.2% vs −65.9%) and the lower return on invested capital (−23.4% vs 0.00%). Across the 16 metrics below, Glass House Brands Inc. leads on 8 and Lifecore Biomedical, Inc. on 8.
Valuation
Profitability
| Metric | GLAS | LFCR | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 31.97% | 27.38% | 53.51% |
| Operating margin | (23.18%) | (5.33%) | 0.00% |
| Net margin | (36.19%) | (65.91%) | (2.45%) |
| Free cash flow margin | (20.78%) | 9.86% | 0.00% |
| Return on equity | (74.02%) | 178.69% | (0.80%) |
| Return on assets | (19.78%) | (32.36%) | (1.67%) |
| Return on invested capital | (23.36%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack